Skip to main content
. Author manuscript; available in PMC: 2024 Apr 11.
Published in final edited form as: J Psychiatr Res. 2022 Oct 10;156:237–244. doi: 10.1016/j.jpsychires.2022.10.020

Table 1.

Demographic and clinical characteristics.

HC (n = 27) Low RNT (n = 49) High RNT (n = 48) p
Age 31.7 ± 10.0 34.8 ± 11.3 34.3 ± 12.5 0.52
Female, n (%) 16 (59.3) 36 (73.5) 35 (72.9) 0.38
Ethnicity, n (%) 0.32
 Asian 1 (3.7) 1 (2.0) 0 (0)
 Black 0 (0) 4 (8.2) 6 (12.5)
 Hispanic 1 (3.7) 2 (4.1) 0 (5.5)
 Native American 2 (7.4) 7 (14.3) 10 (20.8)
 White 23 (85.2) 34 (69.4) 30 (62.5)
 Other 0 (0) 1 (1.0) 2 (4.2)
Education, n (%) 0.58
 No High School 0 (0) 1 (2.0) 4 (8.3)
 High School 4 (14.8) 8 (16.3) 7 (14.6)
 Some College 10 (37.0) 21 (42.9) 20 (41.7)
 College or Higher 13 (48.1) 19 (38.8) 17 (35.4)
BMI 27.67 (6.37) 28.28 (5.53) 28.30 (5.52) 0.88
Employed, n (%) 20 (76.9) 28 (62.2) 30 (63.8) 0.41
Income ($) $47,020 (38,385) $51,681 (46,291) $39,577 (35,235) 0.42
Psychotropic Medication, n (%) 4 (14.8) 30 (61.2) HC 30 (62.5) HC <0.001
OASIS 1.15 (1.61) 9.63 (3.10) HC 10.35 (3.47) HC <0.001
PHQ-9 0.89 (1.48) 13.69 (3.58) HC 14.27 (4.38) HC <0.001
RRS 29.15 (6.76) 47.8 (5.94)HC, H–RNT 64.6 (6.10)HC, L–RNT <0.001
WHODAS 13.48 (3.07) 23.47 (7.0)HC 26.12 (8.21)HC <0.001

Abbreviations: HC, Healthy Control; H-RNT, High repetitive negative thinking; L-RNT, Low repetitive negative thinking; MDD, major depressive disorder; OASIS, Overall Anxiety Severity and Impairment Scale; PHQ-9, Patient Health Questionnaire; RRS, Ruminative Response Scale; WHODAS, World Health Organization Disability Assessment Schedule.